• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    AstraZeneca Pharma India Ltd.
    22 Jul 2025
    8811.50
    -2.39%
    AstraZeneca unveils $50 bn US investment as pharma tariff threat looms
    Business Standard
    On Monday, AstraZeneca said the expansion supports its ambition to reach $80 billion in annual revenue by 2030, with half coming from the US
    Copy LinkShare onShare on Share on Share on
    AstraZeneca Pharma India Ltd. is trading below its 50 day SMA of 8840.3
    logo
    Blue Jet Healthcare Ltd
    22 Jul 2025
    645.90
    -2.85%
    Blue Jet Healthcare shares drop 10% post Q1 results; details here
    Business Standard
    At 2:30 PM, shares of Blue Jet Healthcare were trading at 906.15, down by 10 per cent on the BSE.
    Copy LinkShare onShare on Share on Share on
    Blue Jet Healthcare Ltd is trading below all available SMAs
    logo
    Dr. Reddy's Laboratories Ltd.
    22 Jul 2025
    1253.10
    -1.73%
    Pharma buzz: 3 stocks set to drive action today
    Business Line
    Key triggers for Erraya Life, Dr Reddy's and Cipla
    Copy LinkShare onShare on Share on Share on
    Dr. Reddy's Laboratories Ltd. is trading below its 30 day SMA of 1280.7
    logo
    Cipla Ltd.
    21 Jul 2025
    1499.40
    -0.68%
    Cipla buys 20% stake in iCaltech to broaden respiratory device portfolio
    Business Standard
    Cipla has acquired a 20% stake in iCaltech Innovations for Rs 5 crore, expanding its presence in the respiratory diagnostics segment with a strategic investment in medical device development
    Copy LinkShare onShare on Share on Share on
    Cipla Ltd. has an average target of 1702.60 from 10 brokers.
    Cipla invests in medical devices company iCaltech Innovations
    Business Line | 21 Jul 2025
    logo
    Sun Pharmaceutical Industries Ltd.
    21 Jul 2025
    Tariff Impact 52 week low
    1586.70
    -2.50%
    Sun Pharma's ILUMYA delivers positive psoriatic arthritis trial results
    Business Standard
    Phase 3 trials show ILUMYA improved PsA symptoms significantly, with no new safety concerns; results support potential regulatory submissions in the US and globally
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors decreased from 1351 to 1326 in Jun 2025 qtr
    logo
    Dr. Reddy's Laboratories Ltd.
    21 Jul 2025
    1253.10
    -1.73%
    Here's what brokerages expect from Dr Reddy's Labs ahead of Q1 show
    Business Standard
    Dr Reddy's Labs Q1 preview: The company's net profit is expected to come at 1,460 crore, marking around 4.9 per cent Y-o-Y increase, on average, as against 1,392.4 crore in Q1 FY25
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 911 to 917 in Jun 2025 qtr.
    logo
    SMS Pharmaceuticals Ltd.
    21 Jul 2025
    251.68
    -7.00%
    Sharda Crop, SMS Pharma among top analyst bets; check target, stop-loss
    Business Standard
    Stocks to buy today: Sharda Cropchem has seen a decisive surge, followed by some profit booking, while SMS Pharmaceuticals has experienced a gradual resurgence over the last couple of trading sessions
    Copy LinkShare onShare on Share on Share on
    SMS Pharmaceuticals Ltd. has lost -13.85% in the last 1 Week
    logo
    Dr. Reddy's Laboratories Ltd.
    20 Jul 2025
    1253.10
    -1.73%
    Dr Reddy's gets seven observations from USFDA for Andhra plant
    Business Line
    USFDA conducted the GMP and a Pre-Approval Inspection at the formulations manufacturing facility from July 10 to 18, 2025, the Hyderabad-based drug major said in the filing
    Copy LinkShare onShare on Share on Share on
    Dr. Reddy's Laboratories Ltd.'s price crossed below 50Day SMA today
    logo
    FDC Ltd.
    18 Jul 2025
    454.15
    -2.15%
    CDSCO revises export NOC guidance document for new drug formulations
    Business Standard
    The CDSCO has updated its guidelines for issuing export NOCs for new drug formulations, including relaxations for FDCs, research-oriented drug batches, and SRA approvals
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors decreased from 121 to 113 in Jun 2025 qtr
    logo
    Dr. Reddy's Laboratories Ltd.
    18 Jul 2025
    1253.10
    -1.73%
    Dr Reddy's Gets Form 483 With Seven Observations From USFDA After Inspection At Andhra Unit
    Dr Reddy's Gets Form 483 With Seven Observations From USFDA After Inspection At Andhra Unit
    NDTV Profit
    The inspection was conducted at Dr Reddy's formulations facility in Andhra Pradesh from July 10 to July 18.
    Copy LinkShare onShare on Share on Share on
    Dr. Reddy's Laboratories Ltd.'s price crossed below 50Day SMA today
    more
    loading
    Trendlyne Logo Trendlyne
    Stay ahead of the market
    Markets Today
    • Nifty 50 today
    • Sensex today
    • Latest Quarterly results
    • FII & DII data today
    Dashboard
    • Industry & Sector analysis
    • ETFs
    • Mutual Funds
    • Bullish & Bearish spread
    • Global Indices
    Tools
    • Compare stocks
    • Widgets
    • Data Downloader
    • Excel Connect
    IPOs
    • Dashboard (Mainboard & SME)
    • Upcoming IPOs
    • Recently Listed IPOs
    • Most Successful IPOs
    Upcoming IPOs
    • Jinkushal Industries
    • Chatterbox Technologies
    • Rukmani Devi Garg Agro Impex
    Quick Links
    • Contact us
    • Blogs
    • FAQs
    Company
    • Privacy
    • Terms of Use
    • Disclaimer
    Trendlyne Products
    • Starfolio
    • SmartOptions
    • Trendlyne US Global
    Get Mobile App
    • Android
    • iOS

    Copyright © 2025 Giskard Datatech Pvt Ltd (RA SEBI Reg No: INH000022507)